Journal of Neuroimmunology

Papers
(The H4-Index of Journal of Neuroimmunology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation84
A systematic review of cases of CNS demyelination following COVID-19 vaccination75
A case of longitudinally extensive transverse myelitis following vaccination against Covid-1968
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception63
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study61
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients60
Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease54
The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases54
Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms49
Inflammation in Huntington's disease: A few new twists on an old tale48
Stress and cancer. Part I: Mechanisms mediating the effect of stressors on cancer44
Protocatechuic acid inhibits inflammatory responses in LPS-activated BV2 microglia via regulating SIRT1/NF-κB pathway contributed to the suppression of microglial activation-induced PC12 cell apoptosi41
The neutrophil-to-lymphocyte ratio in Alzheimer's disease: Current understanding and potential applications40
Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature40
Involvement of NFƙB and MAPK signaling pathways in the preventive effects of Ganoderma lucidum on the inflammation of BV-2 microglial cells induced by LPS39
Stellate ganglion block reduces symptoms of Long COVID: A case series38
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure33
Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4/Myd88/NF-κB pathway33
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?33
Toll-like receptors in Alzheimer's disease33
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature33
Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report32
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement31
Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine31
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment31
MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages29
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation28
Searching for autoimmune encephalitis: Beware of normal CSF28
0.030884027481079